Proven operational leader brings proven best practices, laser focus on operational excellence to help sponsors and CROs improve the patient experience in global trials of all sizes and scale.
ClinOne, an industry leader in virtual patient management, adds another key leader to its executive team by tapping clinical research expert Keli Platco (LinkedIn) as Senior Vice President of Operations. Keli’s addition underscores ClinOne’s commitment to building a world-class and proven team to ensure customer success as demand for its platform continues to soar.
With more than 20 years of industry experience, Keli brings a relentless focus on building best practices and ensuring the ongoing improvement of global technology implementations. Throughout her distinguished career, Keli has overseen all aspects of patient- and site-facing solutions from planning and governance through endpoint data management and closeout.
"No matter how intuitive and valuable any clinical technology is, much of its success rests in the hands of the people who collaborate with sponsors and CROs in support of patients and sites," says Rob Bohacs (LinkedIn), co-founder and CEO of ClinOne. "That’s why we are absolutely committed to bringing in the best and most experienced leaders for our team in all areas of the company, including Operations, as we scale. Thanks to people like Keli, our customers have peace of mind that we are a partner they can trust to safeguard their invaluable endpoint data with full support, accountability, and transparency. Keli is a tremendous asset to ClinOne, and we are absolutely thrilled to have her join the team."
Keli joins ClinOne from Signant Health, where she was the Vice President of Client Services and Project Management. In her role she was responsible for Signant’s global service delivery organization across multiple service lines. Previously, she experienced a unique and expansive view of clinical research and drug development with positions ranging from the academic level at the University of Pennsylvania to a global pharmaceutical company at Merck.
"I joined this industry 20 years ago because I am passionate about being part of our shared mission to improve lives in a positive way – and the power and possibilities of clinical research have never been more evident or important than they are right now," says Keli. "We have entered a time of unprecedented opportunity to transform the way clinical research is conducted. With cutting-edge technologies to improve the patient experience and a laser focus on customer service and operational excellence, we will collaborate to overcome traditional barriers to adoption and help customers bring life-changing therapies to patients faster than ever. The ClinOne platform is built with patients in mind and is developed by innovative leaders willing challenge the status quo. I could not be more excited or proud to be part of this team."
The ClinOne solution and its suite of products are proven to accelerate clinical trial enrollment and remote patient care, compliance, and retention. The company’s sole mission is to strengthen connectively and management of participating researchers, patients, and caregivers on-site and remotely. ClinOne’s systems are HIPAA, FDA CRF 21 Part 11, and GDPR compliant and validated and have been used across 55 countries by more than 50 sponsors and 90,000 investigators since 2016. To learn more, visit www.clinone.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210118005328/en/